# Requires notice of adverse step therapy determinations

**Bill ID:** S2677A
**Session:** 2023
**Sponsor:** Neil D. Breslin
**Status:** Senate Floor Calendar

## Summary

Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  2677
 
  2023-2024 Regular Sessions
 
  I N  S E N A T E
 
  January 24, 2023
  ___________
 
 Introduced  by  Sen. BRESLIN -- read twice and ordered printed, and when
  printed to be committed to the Committee on Insurance
 
 AN ACT to amend the insurance law and the public health law, in relation
  to requiring notice of adverse step therapy determinations
 
  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section  1.  Subsection  (a)  of  section 4902 of the insurance law is
 amended by adding a new paragraph 14 to read as follows:
  (14) ESTABLISHMENT OF A WRITTEN PROCEDURE TO ASSURE THAT THE NOTICE OF
 AN ADVERSE DETERMINATION IN RELATION TO A STEP THERAPY PROTOCOL OVERRIDE
 DETERMINATION REQUEST INCLUDES:
  (I) THE REASONS FOR THE DETERMINATION INCLUDING THE  CLINICAL  RATION-
 ALE, IF ANY;
  (II)  INSTRUCTIONS  ON  HOW TO INITIATE STANDARD AND EXPEDITED APPEALS
 PURSUANT TO SECTION FOUR THOUSAND NINE HUNDRED FOUR OF THIS ARTICLE  AND
 AN  EXTERNAL APPEAL PURSUANT TO SECTION FOUR THOUSAND NINE HUNDRED FOUR-
 TEEN OF THIS ARTICLE;
  (III) INFORMATION THAT INCLUDES: ANY  APPLICABLE  ALTERNATIVE  COVERED
 MEDICATIONS;  THE  CLINICAL  REVIEW  CRITERIA  RELIED  UPON TO MAKE SUCH
 DETERMINATION; AND ANY ADDITIONAL NECESSARY  INFORMATION  THAT  MUST  BE
 PROVIDED  TO,  OR  OBTAINED BY, THE UTILIZATION REVIEW AGENT IN ORDER TO
 RENDER A DECISION ON THE APPEAL.
  ยง 2. Section 4903 of the insurance law is  amended  by  adding  a  new
 subsection (e-1) to read as follows:
  (E-1)  NOTICE OF AN ADVERSE DETERMINATION MADE BY A UTILIZATION REVIEW
 AGENT IN RELATION TO A  STEP  THERAPY  PROTOCOL  OVERRIDE  DETERMINATION
 REQUEST SHALL BE MADE IN WRITING TO THE INSURED OR THE INSURED'S AUTHOR-
 IZED  REPRESENTATIVE  AND  THE INSURED'S PRESCRIBING HEALTH CARE PROFES-
 SIONAL AS DEFINED IN SUBSECTION (F) OF  SECTION  FORTY-NINE  HUNDRED  OF
 THIS CHAPTER, AND SHALL INCLUDE:
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD02500-01-3
 S. 2677  2
 
  (I)  THE  REASONS FOR THE DETERMINATION INCLUDING THE CLINICAL RATION-
 ALE, IF ANY;
  (II)  INSTRUCTIONS  ON  HOW TO INITIATE STANDARD AND EXPEDITED APPEALS
 PURSUANT TO SECTION FOUR THOUSAND NINE HUNDRED FOUR OF THIS ARTICLE  AND
 AN  EXTERNAL APPEAL PURSUANT TO SECTION FOUR THOUSAND NINE HUNDRED FOUR-
 TEEN OF THIS ARTICLE;
  (III) INFORMATION THAT INCLUDES: ANY  APPLICABLE  ALTERNATIVE  COVERED
 MEDICATIONS;  THE  CLINICAL  REVIEW  CRITERIA  RELIED  UPON TO MAKE SUCH
 DETERMINATION; AND ANY ADDITIONAL NECESSARY  INFORMATION  THAT  MUST  BE
 PROVIDED  TO,  OR  OBTAINED BY, THE UTILIZATION REVIEW AGENT IN ORDER TO
 RENDER A DECISION ON THE APPEAL.
  ยง 3. Subdivision 1 of section 4902 of the public health law is amended
 by adding a new paragraph (l) to read as follows:
  (L) ESTABLISHMENT OF A WRITTEN PROCEDURE TO ASSURE THAT THE NOTICE  OF
 AN ADVERSE DETERMINATION IN RELATION TO A STEP THERAPY PROTOCOL OVERRIDE
 DETERMINATION  REQUEST  INCLUDES:  (I) THE REASONS FOR THE DETERMINATION
 INCLUDING THE CLINICAL RATIONALE, IF ANY; (II) INSTRUCTIONS  ON  HOW  TO
 INITIATE  STANDARD  AND EXPEDITED APPEALS PURSUANT TO SUBDIVISION TWO OF
 SECTION FORTY-NINE HUNDRED FOUR OF THIS TITLE  AND  AN  EXTERNAL  APPEAL
 PURSUANT  TO  SECTION FORTY-NINE HUNDRED FOURTEEN OF THIS ARTICLE; (III)
 INFORMATION THAT INCLUDES: ANY APPLICABLE  ALTERNATIVE  COVERED  MEDICA-
 TIONS;  THE  CLINICAL  REVIEW CRITERIA RELIED UPON TO MAKE SUCH DETERMI-
 NATION; AND ANY ADDITIONAL NECESSARY INFORMATION THAT MUST  BE  PROVIDED
 TO,  OR  OBTAINED  BY, THE UTILIZATION REVIEW AGENT IN ORDER TO RENDER A
 DECISION ON THE APPEAL.
  ยง 4. Section 4903 of the public health law is amended by adding a  new
 subdivision 5-a to read as follows:
  5-A.  NOTICE  OF AN ADVERSE DETERMINATION MADE BY A UTILIZATION REVIEW
 AGENT IN RELATION TO A  STEP  THERAPY  PROTOCOL  OVERRIDE  DETERMINATION
 REQUEST  SHALL  BE  MADE  IN  WRITING  TO THE ENROLLEE OR THE ENROLLEE'S
 AUTHORIZED REPRESENTATIVE AND THE  ENROLLEE'S  PRESCRIBING  HEALTH  CARE
 PROFESSIONAL AS DEFINED IN SUBDIVISION SIX OF SECTION FORTY-NINE HUNDRED
 OF THIS TITLE, AND SHALL INCLUDE:
  (A)  THE  REASONS FOR THE DETERMINATION INCLUDING THE CLINICAL RATION-
 ALE, IF ANY;
  (B) INSTRUCTIONS ON HOW TO INITIATE  STANDARD  AND  EXPEDITED  APPEALS
 PURSUANT  TO  SECTION  FORTY-NINE  HUNDRED  FOUR  OF  THIS  TITLE AND AN
 EXTERNAL APPEAL PURSUANT TO SECTION FORTY-NINE HUNDRED FOURTEEN OF  THIS
 ARTICLE;
  (C)  INFORMATION  THAT  INCLUDES:  ANY  APPLICABLE ALTERNATIVE COVERED
 MEDICATIONS; THE CLINICAL REVIEW  CRITERIA  RELIED  UPON  TO  MAKE  SUCH
 DETERMINATION;  AND  ANY  ADDITIONAL  NECESSARY INFORMATION THAT MUST BE
 PROVIDED TO, OR OBTAINED BY, THE UTILIZATION REVIEW AGENT  IN  ORDER  TO
 RENDER A DECISION ON THE APPEAL.
  ยง  5.  This  act shall take effect on the ninetieth day after it shall
 have become a law. Effective immediately, the addition, amendment and/or
 repeal of any rule or regulation necessary  for  the  implementation  of
 this  act  on its effective date are authorized to be made and completed
 on or before such effective date.